Wexford Capital’s Alkermes ALKS Stock Holding History

Wexford Capital’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-6,400	Closed	-$282K	–	114
2014 Q1	$282K	Buy	+6,400	New	+$305K	0.02%	162

Other funds holding ALKS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wexford Capital's ALKS Position: Q3 2017 in Review

Wexford Capital sold out of Alkermes (ALKS) in Q3 2017, closing a stake of 6,300 shares — an estimated $365K sold.

Wexford Capital first reported a position in ALKS in Q3 2013 and held it in 5 quarters. The position peaked at $1.34M in Q3 2013. 244 funds tracked by Wall St. Rank hold ALKS as of Q3 2017.

Wexford Capital reported no remaining Alkermes position as of Q3 2017 after selling out during the quarter.
Wexford Capital sold 6,300 Alkermes shares in Q3 2017, an estimated $365K.
Wexford Capital first reported a position in Alkermes in Q3 2013 and held it in 5 quarters.
Wexford Capital's Alkermes position peaked at $1.34M in Q3 2013.
244 funds tracked by Wall St. Rank held Alkermes as of Q3 2017.

Based on Wexford Capital's 13F filing for Q3 2017, filed 13 Nov 2017.